Fernando Marín

Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial

David L. Kendler, Fernando Marín, Cristiano A. F. Zerbini et al. · The Lancet · 2017 · 554 citations · Full text

Bone Disease, Bone Health, New Fractures +8

Quantitative computed tomographic assessment of the effects of 24 months of teriparatide treatment on 3D femoral neck bone distribution, geometry, and bone strength: Results from the EUROFORS study

Jan Borggrefe, Christian Graeff, Thomas Nickélsen et al. · Journal of Bone and Mineral Research · 2009 · 111 citations · Full text

Osteoporosis Drugs, Severe Osteoporosis, Surgery +16

Effects of Teriparatide Compared with Risedronate on the Risk of Fractures in Subgroups of Postmenopausal Women with Severe Osteoporosis: The VERO Trial

Piet Geusens, Fernando Marín, David L. Kendler et al. · Journal of Bone and Mineral Research · 2018 · 109 citations · Full text

Fracture Diagnostics, Severe Osteoporosis, Osteoporosis +18

Real-world effectiveness of teriparatide on fracture reduction in patients with osteoporosis and comorbidities or risk factors for fractures: Integrated analysis of 4 prospective observational studies

Bente Langdahl, Stuart L. Silverman, Saeko Fujiwara et al. · Bone · 2018 · 101 citations · Full text

Bone Disease, Skeletal Trauma, Fracture Reduction +9

Effects of Teriparatide Compared with Risedronate on Recovery After Pertrochanteric Hip Fracture

Per Aspenberg, Jorge Malouf, Umberto Tarantino et al. · Journal of Bone and Joint Surgery · 2016 · 56 citations · Full text